Author

Alexis Wilson

Wayne State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Izabela PodgorskiiD· 2 shared Mackenzie K. HerrooniD· 2 shared Gioia HeraviiD· 1 shared Jacob Lindquist· 1 shared Jing LiiD· 1 shared Kezhong Zhang· 1 shared Laimar C. Garmo· 1 shared Nivisa VakeesaniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Izabela PodgorskiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting SCD in SCD-amplified prostate cancer inhibits growth in bone by modulating cellular stress, mTOR, and DNA damage pathways

Alexis Wilson, Mackenzie K. Herroon, Shane Mecca, Laimar C. Garmo, Jacob Lindquist, Shrila Rajendran, Steve M. Patrick, Izabela Podgorski

This study shows SCD inhibition in prostate cancer reduces tumor growth in bone by affecting cellular stress, mTOR, and DNA damage pathways.

bioRxiv · Jun 9, 2025 · PreprintCancer Biology

Targeting Fatty Acid Desaturase I Inhibits Renal Cancer Growth Via ATF3-mediated ER Stress Response

Gioia Heravi, Zhenjie Liu, Mackenzie K. Herroon, Alexis Wilson, Yang-Yi Fan, Yang Jiang, Nivisa Vakeesan, Tao Li, Zheyun Peng, Kezhong Zhang, Jing Li, Robert S. Chapkin, Izabela Podgorski, Wanqing Liu

This study shows that inhibiting FADS1 reduces renal cancer growth by inducing ER stress and ATF3-mediated responses, highlighting FADS1 as a therapeutic target.

Biomedicine & Pharmacotherapy · Mar 23, 2025Peer-reviewedCancer Biology